èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ããEdesa Biotech, Inc.ã¯ãççæ§çŸæ£ããã³å
ç«é¢é£çŸæ£ã«å¯Ÿããå»è¬åã®ç ç©¶éçºã補é ãããã³åååã«æºãã£ãŠããŸããäž»å補ååè£ã¯ãCOVID-19æ£è
ã®æ¥æ§åŒåžçª®è¿«çåçŸ€ã®æ²»çãç®çãšãã第2çž/第3çžèšåºè©Šéšäžã®ã¢ãã¯ããŒãã«æäœEB05ãšãæ
¢æ§ã¢ã¬ã«ã®ãŒæ§æ¥è§Šç®èçã®æ²»çãç®çãšãã第2Bçžèšåºè©Šéšäžã®éã¹ããã€ãæ§æççååç©ãå«ã屿çšã¯ãªãŒã EB01ã§ããå瀟ã¯ãŸããççŸæ£ã«äŒŽãçŽ
æãè
«ããæ»²åºæ¶²ã®æ²»çãç®çãšããsPLA2æççã¯ãªãŒã ã®å»¶é·ã§ããEB02ãšãã¢ãã¯ããŒãã«æäœåè£EB06ãéçºããŠããŸããå瀟ã¯NovImmune SAãšååå¥çŽãç· çµããããããã³åç©ã®æ²»çãäºé²ã蚺æçšéã§Tollæ§å容äœ4ããã³ã±ã¢ã«ã€ã³ãªã¬ã³ã10ãå«ã補åãéçºããŠããŸããããã³ Yissum Research Development Company ãšææºããç®èããã³èéçŽè
žå±æãžã®é©çšããªãã³ã«ç®èç§ããã³èè
žçŸæ£ã§ã®äœ¿çšãç®çãšããæ²»çãäºé²ã蚺æçšã®è£œåã®éçºãè¡ã£ãŠããŸããEdesa Biotech, Inc. 㯠2015 幎ã«èšç«ãããã«ããã®ããŒã«ã ã«æ¬ç€Ÿã眮ããŠããŸãã